2022 ASCRS Annual Meeting
Satellite CME Programs
Anterior Segment Surgeon's Guide to Thyroid Eye Disease
PARTICIPATE AND CLAIM CME AT YOUR CONVENIENCE
Join faculty for a brand new Satellite CME program on thyroid eye disease for the anterior segment surgeon. The program will define pathogenesis, risk, and diagnosis of thyroid eye disease and treatment options, including steroids, immunosuppressants, teprotumumab, and investigational biologics. Case presentations will be included.
The American Society of Cataract and Refractive Surgery designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™.
ASCRS gratefully acknowledges the unrestricted educational grants received in support of this program from:
Horizon Therapeutics
Activity Agenda
Introductory Remarks
Wendy W. Lee, MD, ABO
Thyroid Eye Disease: Defining Factors in Pathogenesis, Risk, and Diagnosis
Prem S. Subramanian, MD, PhD, ABO
Case Presentation: Diagnosing Thyroid Eye Disease
Wendy W. Lee, MD, ABO
Treatment of Thyroid Eye Disease: What We Know and What’s New
Jennifer Murdock, MD, ABO
Case Presentation: Treating Thyroid Eye Disease
Wendy W. Lee, MD, ABO
Faculty
Wendy W. Lee, MD, ABO
Jennifer Murdock, MD, ABO
